Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers
Clinical trial NCT04535414 · COMPLETED
Trial details
- NCT number
- NCT04535414
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-22
- Primary completion
- 2024-09-12
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.